Kamada Ltd. Logo

Kamada Ltd.

A biopharmaceutical company specializing in plasma-derived protein therapeutics.

KMDA | TA

Overview

Corporate Details

ISIN(s):
IL0010941198
LEI:
Country:
Israel
Address:
2 Holzman St, Science Park, 7670402 Rehovot

Description

Kamada Ltd. is a vertically integrated global biopharmaceutical company specializing in plasma-derived protein therapeutics. The company develops, manufactures, and commercializes a portfolio of products for rare and serious conditions, with a focus on therapeutic areas such as Alpha-1 Antitrypsin Deficiency (AATD) and Cytomegalovirus (CMV) prevention in transplant patients. Kamada utilizes a proprietary platform technology for advanced protein extraction and purification from human plasma. In addition to its marketed products, the company maintains a development pipeline of new therapies, including an inhaled treatment for AATD.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-14 16:00
Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year …
English 8.4 MB
2025-05-14 16:00
Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year …
English 36.5 KB
2025-05-07 16:00
Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025
English 151.4 KB
2025-05-07 16:00
Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025
English 36.3 KB
2025-05-05 16:00
Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for …
English 178.4 KB
2025-05-05 16:00
Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for …
English 36.5 KB
2025-03-24 14:04
Kamada Updates on Withholding Tax Procedures on Previously Announced Special Ca…
English 146.0 KB
2025-03-24 14:04
Kamada Updates on Withholding Tax Procedures on Previously Announced Special Ca…
English 36.4 KB
2025-03-19 14:00
Kamada Announces Expansion of Plasma Collection Operations with the Opening of …
English 181.2 KB
2025-03-19 14:00
Kamada Announces Expansion of Plasma Collection Operations with the Opening of …
English 36.5 KB
2025-03-05 15:10
20F Annual filing 2024
English 2.1 MB
2025-03-05 15:10
20F Annual filing 2024
English 36.5 KB
2025-03-05 15:05
financial results for the three months and year ended December 31, 2024
English 4.7 MB
2025-03-05 15:05
financial results for the three months and year ended December 31, 2024
English 36.5 KB
2025-02-26 15:00
Fourth Quarter and Fiscal Year 2024 Financial Results and conference call on Ma…
English 187.8 KB

Automate Your Workflow. Get a real-time feed of all Kamada Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kamada Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kamada Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.